Informations générales (source: ClinicalTrials.gov)

NCT05493605 En recrutement IDF
Cardiac Involvement in Wilson's Disease (WIL-HEART)
Interventional
  • Dégénérescence hépatolenticulaire
N/A
Fondation Ophtalmologique Adolphe de Rothschild (Voir sur ClinicalTrials)
mars 2023
mars 2026
29 juin 2024
Heart damage by copper accumulation has been reported in Wilson's Disease. However, the disease epidemiology is still poorly understood. A number of studies on pediatric populations have not shown any significant cardiac involvement apart from early dysautonomia. This could suggest that the clinical manifestations related to the copper accumulation in the heart appears with the duration of the disease. Case-control studies on adult populations have highlighted various electrocardiographic (ECG) abnormalities more frequent in patients with Wilson's Disease than in healthy volunteers, but all these studies involved small number of patients (maximum 60). The hypothesis is that there is cardiac involvement in Wilson's Disease, requiring screening, follow-up and appropriate support.
 Voir le détail

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
HOPITAL FONDATION A. DE ROTHSCHILD Aurélia POUJOIS En recrutement IDF 21/06/2024 13:34:39  Contacter

Critères

Tous
Inclusion Criteria:

- Adult patient with Wilson's disease confirmed by a Leipzig score ≥ 4

- Express consent to participate in the study by the patient or legal guardian in the
case of patients under guardianship or by the patient assisted by his curator in the
case of patients under guardianship

- Member of or beneficiary of a Social Security scheme


- Absolute or relative contraindication to MRI or contrast media

- Pregnant, parturient or breast-feeding women: a urine pregnancy test will be carried
out in women of childbearing age

- Patient with hepatic decompensation (Child-Pugh score stage C)

- Patient in neuro-psychiatric decompensation